Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

A more scientific jump-start to the economy

Ian M. Kahane, MD
Conditions
April 26, 2020
Share
Tweet
Share

In March and April 2020, the United States federal government threw billions of dollars at new programs designed to keep the economy going strong for a few additional months. They have a litany of acronyms for these programs, including the PPP, SBA, and more, but the one acronym they really need to focus on is all but ignored: IgG.

Many medical students and residents studying for their exams know the mnemonic: IgG means a virus is gone, IgM means you have a virus at that moment. This concept applies to most viruses; that if a person tests IgG positive for that specific virus, it means they had and successfully cleared an infection from that invader. It is not routinely tested, but it is a simple blood test, and each virus has its own unique IgG and IgM test.

IgG and IgM testing for COVID-19 has existed for a few weeks already, but it is challenging to locate. When physicians are able to access it, it is either costly or runs out of stock too expeditiously.

Understanding this concept is the quickest way to restart the economy. It boils down to this: My cousin is a firefighter in Miami. Firefighters are heroes and absolutely essential, so the entire firehouse got tested for COVID-19 IgG and IgM. My cousin wound up testing IgG positive. Neither he, nor his immunocompromised wife, nor his three children ever had any real symptoms of the virus.

Now while this is not a guarantee, this would likely be a strong indicator that it would be safe for him and his family to go to restaurants, a movie theater, to work, etc. I would still encourage mask wearing to protect others, and we can open these commercial venues methodically. Those testing negative should still stay home for their own protection and the protection of others.

However, those individuals who are IgG positive and were asymptomatic are likely safe to return to a somewhat normal activity level. Even if there is a re-exposure risk, odds are they would have no symptoms when contracting COVID-19, as they did their first time. This would jump-start the economy better than any economic stimulus or acronym anyone could think about. People could spend money at restaurants, nail salons, and other commercial businesses that are currently reeling in this crisis. The United States government must act now and make IgG testing quickly and cheaply available.

Ian M. Kahane is an internal medicine physician.

Image credit: Shutterstock.com 

Prev

Hearing his father's words, a physician re-enters the fray

April 26, 2020 Kevin 0
…
Next

During the pandemic, a physician says: "Put me in, Coach"

April 26, 2020 Kevin 0
…

Tagged as: COVID, Infectious Disease

Post navigation

< Previous Post
Hearing his father's words, a physician re-enters the fray
Next Post >
During the pandemic, a physician says: "Put me in, Coach"

ADVERTISEMENT

More by Ian M. Kahane, MD

  • The hidden ventilators in America

    Ian M. Kahane, MD

Related Posts

  • Wellness initiatives can start in the medical library

    Sheryl Ramer
  • How to start reversing the clinician shortage today

    Timothy Lee, MPH
  • Burnout doesn’t start in medical school

    Anna Goshua
  • Start with the students: Addressing the future of physician suicide

    Anonymous
  • If you don’t teach IMGs, maybe you should start

    Denelle Mohammed
  • To change the culture, start with clinical education

    Anonymous

More in Conditions

  • Is white coat hypertension harmless?

    Monzur Morshed, MD and Kaysan Morshed
  • Gen Z, ADHD, and divided attention in therapy

    Ronke Lawal
  • Early-onset breast cancer: a survivor’s story

    Sara Rands
  • Remote second opinions for equitable cancer care

    Yousuf Zafar, MD
  • Why psychiatrists can’t treat family members

    Farid Sabet-Sharghi, MD
  • Aging parents and Thanksgiving: a gentle check-in

    Barbara Sparacino, MD
  • Most Popular

  • Past Week

    • Is white coat hypertension harmless?

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • A new autism care model in Idaho

      Ronald L. Lindsay, MD | Conditions
    • Protecting elder clinicians from violence

      Gerald Kuo | Conditions
    • China’s health care model of scale and speed

      Myriam Diabangouaya, MD & Vikram Madireddy, MD | Physician
    • The myth of endless availability in medicine

      Emmanuel Chilengwe | Conditions
    • Bureaucratic evil in modern health care

      Dr. Bryan Theunissen | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
  • Recent Posts

    • Is white coat hypertension harmless?

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • How to fight for your loved one during a medical crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Is trauma surgery a dying field?

      Farshad Farnejad, MD | Physician
    • Gen Z, ADHD, and divided attention in therapy

      Ronke Lawal | Conditions
    • Innovation in medicine: 6 strategies for docs

      Jalene Jacob, MD, MBA | Tech
    • Why we fund unproven autism therapies

      Ronald L. Lindsay, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 3 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Is white coat hypertension harmless?

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • A new autism care model in Idaho

      Ronald L. Lindsay, MD | Conditions
    • Protecting elder clinicians from violence

      Gerald Kuo | Conditions
    • China’s health care model of scale and speed

      Myriam Diabangouaya, MD & Vikram Madireddy, MD | Physician
    • The myth of endless availability in medicine

      Emmanuel Chilengwe | Conditions
    • Bureaucratic evil in modern health care

      Dr. Bryan Theunissen | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
  • Recent Posts

    • Is white coat hypertension harmless?

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • How to fight for your loved one during a medical crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Is trauma surgery a dying field?

      Farshad Farnejad, MD | Physician
    • Gen Z, ADHD, and divided attention in therapy

      Ronke Lawal | Conditions
    • Innovation in medicine: 6 strategies for docs

      Jalene Jacob, MD, MBA | Tech
    • Why we fund unproven autism therapies

      Ronald L. Lindsay, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

A more scientific jump-start to the economy
3 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...